Edward joined us as a partner in June, 2021. He came to Sofinnova Partners from M Ventures, Merck KGaA’s corporate VC arm, where he focused on investments in cutting-edge digital medicine companies, including Akili Interactive Labs, maker of the first FDA-approved prescription videogame. Before that, Edward was in the Life Sciences securities team at Kempen & Co, a pan-European merchant bank, covering listed small- and mid-cap life sciences equities. He started his career as an analyst within the biopharma investment team of M Ventures. Edward is positive, energetic and purpose-driven — and he enjoys ...read more